The IFNγ increases the expression of the PD-L1 protein on T cells and tumor cells, which promotes the PD-1 receptor of T cells to inhibit the antitumor immunity 41, and the deletion of PD-1 elevated the antitumor efficacy of CAR-T cells 28. Here, PDCD1 is linked to neoplasm.